Institutional
Andera Partners
CIK 0001757283
$206.5M
Reported AUM
8
Positions
Q2 2026
Period
2026-07-22
Filed
Editorial summary
Summary for Andera Partners · Q2 2026 is not yet generated. It will appear here after the next nightly run.
Portfolio · Q2 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KMTS | KESTRA MED TECHNOLOGIES LTD | $23.15 | 1.76% | 50.52% | -3.78% | $69.4M | 33.62% | — | HELD |
| 2 | MLYS | MINERALYS THERAPEUTICS INC | $26.19 | -0.61% | 90.49% | 66.22% | $42.9M | 20.80% | — | HELD |
| 3 | AVLN | AVALYN PHARMACEUTICALS INC | $29.31 | 4.31% | -3.49% | 0.07% | $30.6M | 14.82% | — | HELD |
| 4 | AGMB | AGOMAB THERAPEUTICS NV | $12.76 | 2.90% | -12.94% | 21.59% | $20.0M | 9.67% | — | HELD |
| 5 | EVMN | EVOMMUNE INC | $11.35 | 2.71% | -39.65% | -35.11% | $18.5M | 8.96% | — | HELD |
| 6 | IVA | INVENTIVA SA | $4.62 | 2.44% | 42.55% | -65.23% | $13.7M | 6.65% | — | HELD |
| 7 | ABVX | ABIVAX SA | $124.33 | 4.62% | 72.81% | 1124.93% | $10.4M | 5.04% | — | HELD |
| 8 | NYXH | NYXOAH S A | $1.41 | 1.44% | -80.55% | -95.70% | $882K | 0.43% | — | HELD |
Source: SEC EDGAR · accession 0001757283-26-000015. 13F discloses long positions only — shorts, foreign equities, and options are excluded.